|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||17.90 - 17.90|
|52-week range||13.09 - 102.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||72.97|
CureVac N.V. ( NASDAQ:CVAC ) shareholders (or potential shareholders) will be happy to see that insider Dietmar Hopp...
Shareholders in CureVac N.V. ( NASDAQ:CVAC ) may be thrilled to learn that the analysts have just delivered a major...
My name is Sarah Fakih, and I'm the vice president of corporate communications and investor relations at CureVac. On the call with me are Franz-Werner Haas, the chief executive officer of CureVac, Klaus Edvardsen, our chief development officer, and Pierre Kemula, chief financial officer of CureVac.